Washington Trust Bank’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Washington Trust Bank’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,500	Closed	-$15K	–	829
2015 Q4	$15K	Hold	2,500	–	–	﹤0.01%	557
2015 Q3	$15K	Hold	2,500	–	–	﹤0.01%	566
2015 Q2	$17K	Hold	2,500	–	–	﹤0.01%	592
2015 Q1	$15K	Hold	2,500	–	–	﹤0.01%	631
2014 Q4	$17K	Hold	2,500	–	–	﹤0.01%	647
2014 Q3	$20K	Hold	2,500	–	–	0.01%	599
2014 Q2	$20K	Hold	2,500	–	–	﹤0.01%	616
2014 Q1	$20K	Buy	+2,500	New	+$21.2K	﹤0.01%	610

Other funds holding SPPI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Washington Trust Bank's SPPI Position: Q1 2016 in Review

Washington Trust Bank sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2016, closing a stake of 2,500 shares — an estimated $15K sold.

Washington Trust Bank first reported a position in SPPI in Q1 2014 and held it in 8 quarters. The position peaked at $20K in Q3 2014. 131 funds tracked by Wall St. Rank hold SPPI as of Q1 2016.

Washington Trust Bank reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
Washington Trust Bank sold 2,500 Spectrum Pharmaceuticals Inc shares in Q1 2016, an estimated $15K.
Washington Trust Bank first reported a position in Spectrum Pharmaceuticals Inc in Q1 2014 and held it in 8 quarters.
Washington Trust Bank's Spectrum Pharmaceuticals Inc position peaked at $20K in Q3 2014.
131 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2016.

Based on Washington Trust Bank's 13F filing for Q1 2016, filed 25 Apr 2016.